- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 233/16 - Radicaux substitués par des atomes d'azote
Détention brevets de la classe C07D 233/16
Brevets de cette classe: 50
Historique des publications depuis 10 ans
|
5
|
4
|
4
|
5
|
5
|
2
|
2
|
1
|
2
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Bayer Pharma AG | 1054 |
4 |
| Ingevity South Carolina, LLC | 249 |
4 |
| GPCP IP Holdings LLC | 1634 |
4 |
| The Regents of the University of California | 20153 |
2 |
| ExxonMobil Research And Engineering Company | 2562 |
2 |
| ACADIA Pharmaceuticals Inc. | 203 |
2 |
| Friedrich-Alexander-Universitaet Erlangen-Nuernberg | 110 |
2 |
| The Lubrizol Corporation | 1290 |
2 |
| The University of North Carolina at Chapel Hill | 2059 |
2 |
| Hoffmann-La Roche Inc. | 3489 |
1 |
| AstraZeneca AB | 2872 |
1 |
| Massachusetts Institute of Technology | 10121 |
1 |
| The Board of Trustees of the Leland Stanford Junior University | 6494 |
1 |
| Dow Global Technologies LLC | 10459 |
1 |
| JPMorgan Chase Bank, National Association | 8597 |
1 |
| Purdue Research Foundation | 3687 |
1 |
| Acuitas Therapeutics Inc. | 118 |
1 |
| Argusina, Inc. | 2 |
1 |
| The Board of Trustees of the University of Alabama | 419 |
1 |
| Ceca S.A. | 45 |
1 |
| Autres propriétaires | 15 |